Aimovig and Sinus congestion - a phase IV clinical study of FDA data

Summary:

Sinus congestion is reported as a side effect among people who take Aimovig (erenumab-aooe), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Vitamin D3, and have Migraine.

The phase IV clinical study analyzes which people have Sinus congestion when taking Aimovig. It is created by eHealthMe based on reports of 49,844 people who have side effects when taking Aimovig from the FDA, and is updated regularly.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

What is Sinus congestion?

Sinus congestion (blockage of sinus) is found to be associated with 1,004 drugs and 955 conditions by eHealthMe. Check the latest studies of Sinus congestion.

On Aug, 11, 2026

49,844 people reported to have side effects when taking Aimovig.
Among them, 23 people (0.05%) have Sinus congestion.

Among these 23 people:

How long have people been on Aimovig when they have Sinus congestion? *

What is the gender of people who have Sinus congestion when taking Aimovig? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Sinus congestion when taking Aimovig? *

What are other drugs people take besides Aimovig? *

Sodium Chloride: 8 people, 34.78%
Heparin: 8 people, 34.78%
Botox: 8 people, 34.78%
Magnesium: 8 people, 34.78%
Vitamin D3: 8 people, 34.78%
Prednisone: 7 people, 30.43%
Eliquis: 7 people, 30.43%
Epinephrine: 7 people, 30.43%
Tizanidine Hydrochloride: 7 people, 30.43%
Lyrica: 6 people, 26.09%

What are other side effects people have besides Sinus congestion? *

Migraine (headache): 14 people, 60.87%
Fever: 10 people, 43.48%
Headache (pain in head): 9 people, 39.13%
Pain: 9 people, 39.13%
Sinusitis (inflammation of sinus): 9 people, 39.13%
Pain In Extremity: 8 people, 34.78%
Fatigue (feeling of tiredness): 8 people, 34.78%
Joint Pain: 8 people, 34.78%
Nasopharyngitis (inflammation of the nasopharynx): 7 people, 30.43%
Rashes (redness): 7 people, 30.43%

What are the existing conditions these people have? *

Migraine (headache): 9 people, 39.13%
Immunodeficiency: 5 people, 21.74%
Immunodeficiency Common Variable: 3 people, 13.04%
Migraine With Aura (headache with vision weakness): 2 people, 8.70%
Epstein-Barr Virus Infection: 2 people, 8.70%
Asthma: 2 people, 8.70%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.35%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 4.35%
Nausea And Vomiting: 1 person, 4.35%
Immune System Disorder: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Aimovig and have Sinus congestion?

- Check whether Sinus congestion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aimovig:

Aimovig (49,930 reports)

Sinus congestion treatments and more:

Sinus congestion (21,241 reports)

Browse all side effects of Aimovig:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus congestion:

Sinus congestion (1,004 drugs)

Browse all the conditions that are associated with Sinus congestion:

Sinus congestion (955 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on erenumab-aooe (the active ingredients of Aimovig) and Aimovig (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.